The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host

QR Code

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host

African horse sickness (AHS) is a lethal equine disease transmitted by Culicoides biting midges and caused by African horse sickness virus (AHSV). AHS is endemic to sub-Saharan Africa, but devastating outbreaks have been recorded periodically outside this region. The perceived risk of an AHS outbrea...

Full description

Bibliographic Details
Main Authors:	Calvo-Pinilla, Eva, Gubbins, Simon, Mertens, Peter P.C., Ortego, Javier, Castillo-Olivares, Javier
Format:	Article
Published:	Elsevier 2018
Subjects:	African horse sickness; Vaccinia; MVA; VP2
Online Access:	https://eprints.nottingham.ac.uk/51470/

Similar Items

Synthesis and application of P4VP based block copolymers from supercritical CO2
by: Larder, Ryan
Published: (2021)

Immunogenicity of AHSV-4 VP7 crystals and their potential use as a vaccine delivery platform
by: Bailey, Laura Victoria
Published: (2016)

Sequence analysis and expression of VP3 gene of chicken anaemia virus
by: M. S., Hasmah, et al.
Published: (2003)

Molecular Characterization of Chicken Anemia Virus (CAV) and Expression of the CAV VP3 Protein
by: Mohtar, Siti Hasmah
Published: (2003)

Development of a Recombinant Retrovirus Expressing the Chicken Anaemia Virus Vp3 Protein
by: Mohd Saad, Suria
Published: (2006)

Development of a DNA vaccine against chicken anemia virus by using a bicistronic vector expressing VP1 and VP2 proteins of CAV.
by: Moeini, Hassan, et al.
Published: (2011)

The Expression of Chicken Anemia Virus Vp3 Gene and Induction of Apoptosis In Transformed and Tumor Cells
by: Ghrici, Mohamed
Published: (2001)

Cloning And Expression Of Nucleocapsid Protein Of Newcastle Disease Virus Fused With Vp5 Gene Of Infectious Bursal Disease Virus
by: Zaid, Shaherny
Published: (2007)

Molecular Characterisation Of Infectious Bursal Disease Virus And Expression Of Vp2 Protein For The Development Of Diagnostic Kit And Recombinant Vaccine
by: Mat Isa, Nurulfiza
Published: (2008)

Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus
by: Omar, Abdul Rahman, et al.
Published: (2006)

Potential usefulness of viral capsid surface proteins (VP1,VP2, VP3 & VP4) for vaccination against common cold
by: Alshrari, Ahmed Subeh D
Published: (2016)

Expression of Iran isolate IBDV VP2 and VPX protein in prokaryotic expression system
by: Hosseini, Seyed Davood, et al.
Published: (2004)

A comparison of the VP1, VP2, and VP4 regions for molecular typing of human enteroviruses
by: Perera, D., et al.
Published: (2010)

Improving the potency of DNA vaccine against Chicken Anemia Virus (CAV) by fusing VP1 protein of CAV to Marek's Disease Virus (MDV) Type-1 VP22 protein.
by: Moeini, Hassan, et al.
Published: (2011)

Pathogenicity and Molecular Characterisation of the VP2 Gene of Infectious Bursal Disease Virus
by: Mahfuzul Hoque, Md
Published: (2001)

Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)

Cloning of Chicken Anaemia Virus (CUX-1) VP1 Gene Into a Lactococcus Expression Vector pMG36e
by: Ng, Perk Tsong
Published: (1999)

Characterisation of the Chimeric Proteins of Vp3 from Chicken Anemia Virus with Nucleoprotein from the Newcastle Disease Virus
by: Othman, Zulkefley
Published: (2006)

Diversity of group A rotavirus on a UK pig farm
by: Chandler-Bostock, Rebecca, et al.
Published: (2015)

Truncated chicken anemia virus-VP3 as a potential anti tumour vaccine
by: Lim, Shen Ni
Published: (2012)

Molecular expression of recombinant Apoptin in planta and preliminary evaluation of biological characteristics of plant-made Apoptin on cancerous cells
by: Chan, Xiao Ying
Published: (2017)

The Nucleocapsid Protein Of Newcastle Disease Virus As A Carrier For The Vp1 Polypeptides Of Enterovirus 71
by: Sivasamugham, Lalita Ambigal
Published: (2005)

Improvement of the Solubility of the Vp2 Hypervariable Region of Infectious Bursal Disease Virus by Fusion to the NP Protein of Newcastle Disease Virus
by: Saadun, Rafidah
Published: (2005)

Use EVA to Measure and Manage Shareholder Value in a Chinese Listed Corporation ------Ningbo Bird Corporation
by: Jiang, Feng
Published: (2007)

The nucleocapsid protein of Newcastle disease virus promotes solubility of the VP2 hypervariable region of infectious bursal disease virus in Escherichia coli
by: Saadun, Rafidah, et al.
Published: (2008)

Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice.
by: Ch'ng, Wei Choong, et al.
Published: (2011)

Antigenic and phylogenetic relationships of outer capsid protein VP2, from multiple bluetongue virus serotypes
by: Fay, Petra Christel
Published: (2018)

Display of the VP1 epitope of foot-and-mouth disease virus on bacteriophage T7 and its application in diagnosis
by: Wong, Chuan Loo, et al.
Published: (2013)

Sequence and phylogenetic analysis of the VP2 gene of very virulent infectious bursal disease virus isolates
by: Hoque, Mahfuzul M., et al.
Published: (2002)

Immunogenicity study of dna vaccine and dna vaccine carrier expressing vp1 of enterovirus 71 in the prime boost vaccination strategy
by: Nur Ayuni, Kadir
Published: (2008)

Pathogenicity of SspI-positive infectious bursal disease virus and molecular characterization of the VP2 hypervariable region
by: Hoque, Md Mahfuzul, et al.
Published: (2001)

Pathogenicity of SspI-positive infectious bursal disease virus and molecular characterization of the VP2 hypervariable region
by: Hoque, Mahfuzul M., et al.
Published: (2001)

Construction Of Recombinant Bcg Expressing The Vp1 Antigen Of Enterovirus 71 For The Development Of A Candidate Vaccine
by: Othman, Nurulhasanah
Published: (2006)

Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)

Variability of White Spot Syndrome Virus (WSSV) envelope protein VP28 from diseased shrimp (Litopenaeus vannamei) in Indonesia
by: Tasakka, A.C.M.A.R., et al.
Published: (2022)

Molecular Studies of a Highly Virulent Strain of Infectious Bursal Disease Virus (IBDV) and Production of VP2 Recombinant Protein
by: Chong, Lee Kim
Published: (2003)

High-level production of VP2 recombinant protein of very virulent infectious bursal disease virus in Escherichia coli system.
by: Bejo, Mohd Hair, et al.
Published: (2008)

Cloning and Expression of Vp2 Gene of Chicken Anemia Vurus Strain Cux-1 in Lactococcus Lactis Mg1363
by: Ahmat, Nurfilza
Published: (2001)

Truncated VP3 protein as anti-tumor agent.
by: Allaudin, Zeenathul Nazariah, et al.
Published: (2010)

Molecular Epidemiology of Human Enterovirus 71 Strains and Recent Outbreaks in the Asia-Pacific Region: Comparative Analysis of the VP1 and VP4 Genes
by: Cardosa, Mary Jane, et al.
Published: (2003)